Skip to main content

Table 2 Influence of patient characteristics and region on Periprosthetic Joint Infection (PJI) rate

From: Variation in Prosthetic Joint Infection and treatment strategies during 4.5 years of follow-up after primary joint arthroplasty using administrative data of 41397 patients across Australian, European and United States hospitals

Variable

Odds Ratio [95% CI]

Age > =70 years

0.75 [0.63-0.89]

Sex (Males versus Females)

1.38 [1.17–1.63]

Comorbidities

 Cardiac arrhythmias (yes/no)

1.32 [0.99–1.74]

 Congestive heart failure (yes/no)

1.58 [0.98–2.53]

 Rheumatoid arthritis, collagen or vascular disease (yes/no)

1.96 [1.39–2.75]

 Diabetes uncomplicated (yes/no)

1.28 [1.00–1.64]

 Coagulopathy (yes/no)

2.28 [1.29–4.03]

 Fluid and electrolyte disorders (yes/no)

1.63 [1.15–2.30]

 Depression (yes/no)

2.04 [1.46–2.86]

Joint (knee versus hip)

1.52 [1.28–1.79]

Region

 Australia versus US

1.40 [1.03–1.91]

 Europe versus US

1.24 [1.01–1.52]

  1. Significant differences are indicated in bold; Model fit: C statistic = 0,61 Nagelkerke R 2 = 0,018